NEW YORK (Reuters Health) – Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to
Continue reading »
mypharmacynews.com
Home ยป
NEW YORK (Reuters Health) – Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to
Continue reading »Contrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a
Continue reading »We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your
Continue reading »Pancreatic cancer is caused by the abnormal and uncontrolled growth of cells in the pancreas, a large gland that’s part
Continue reading »Scientists in Cambridge and London have developed a catalogue of DNA mutation ‘fingerprints’ that could help doctors pinpoint the environmental
Continue reading »Every day, more than 1,200 people worldwide will be diagnosed with pancreatic cancer and an estimated 1,180 die from the
Continue reading »The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has
Continue reading »When scientists at The University of Texas Health Science Center at Houston (UTHealth) applied a chemical found in soybeans to
Continue reading »In 1995, two University of Chicago-based cancer specialists suggested there was an intermediate state — somewhere between curable localized cancers
Continue reading »German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer
Continue reading »